Uri Ladabaum

Publication Details

  • Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates.

    Rubenstein JH, Waljee AK, Jeter JM, Velayos FS, Ladabaum U, Higgins PD. Am J Gastroenterol. 2009; 104 (9): 2222-32

    Colorectal cancer (CRC) is a feared complication of chronic ulcerative colitis (UC). Annual endoscopic surveillance is recommended for the detection of early neoplasia. 5-Aminosalicylates (5-ASAs) may prevent some UC-associated CRC. Therefore, in patients prescribed 5-ASAs for maintenance of remission, annual surveillance might be overly burdensome and inefficient. We aimed to determine the ideal frequency of surveillance in patients with UC maintained on 5-ASAs.

    PubMedID: 19491824

Stanford Medicine Resources:

Footer Links: